as on January 28, 2026 at 9:37 pm IST
Day's Low
Day's High
0.69%
Downside
3.81%
Upside
52 Week's Low
52 Week's High
58.17%
Downside
3.09%
Upside
Check Kiniksa Pharmaceuticals International Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
1.109
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
5.50%
PE Ratio (TTM)
96
Industry PE ratio
-2.8168481375358168
PEG Ratio
0EBITDA
39.6M
Revenue (TTM)
598.0M
Profit Margin
6.01%
Return On Equity TTM
7.39%
Track how Kiniksa Pharmaceuticals International Plc P/E has moved over time to understand its valuation trends.
Kiniksa Pharmaceuticals International Plc in the last 5 years
Lowest (-174.01x)
September 30, 2024
Industry (-2.82x)
January 28, 2026
Today (96.00x)
January 28, 2026
Highest (177.55x)
March 31, 2024
Today’s Price to Earnings Ratio: 96.00x
Compare market cap, revenue, PE, and other key metrics of Kiniksa Pharmaceuticals International Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.3B | 134.45% | 96 | 6.01% | |
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -23.68% | -21.95 | -26.13% |
The Kiniksa Pharmaceuticals International Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kiniksa Pharmaceuticals International Plc investment value today
Current value as on today
₹2,20,642
Returns
₹1,20,642
(+120.64%)
Returns from Kiniksa Pharmaceuticals International Plc Stock
₹1,14,668 (+114.67%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Kiniksa Pharmaceuticals International Plc. Average target price of $55
Get share price movements and forecasts by analysts on Kiniksa Pharmaceuticals International Plc.
What analysts predicted
21.24%UPSIDE
Target Price
$55
Current Price
$43.32
Analyzed by
11 Analysts
Target
$55.00
Kiniksa Pharmaceuticals International Plc target price $55, a slight upside of 21.24% compared to current price of $43.32. According to 11 analysts rating.
Search interest for Kiniksa Pharmaceuticals International Plc Stock has increased by 224% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:224% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, KNSA stock has moved up by 65.1%
Profit Spike
![]()
Netprofit is up for the last 5 quarters, -12.69M → 18.43M (in $), with an average increase of 75.6% per quarter
Revenue Rich
![]()
Revenue is up for the last 7 quarters, 79.85M → 180.85M (in $), with an average increase of 12.4% per quarter
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3962.6% return, outperforming this stock by 3743.5%
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 28567.3% return, outperforming this stock by 28446.1%
| Organisation | Kiniksa Pharmaceuticals International Plc |
| Headquarters | 23 Old Bond Street, London, United Kingdom, WIS 4PZ |
| Industry | Health Technology |
| CEO | Mr. Sanj K. Patel |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Sanj K. Patel | CEO & Chairman of the Board |
Jonathan Kirshenbaum | Investor Relations Officer |
Ms. Megan Woods M.B.A. | Senior VP & Chief Human Resources Officer |
Mr. Eben Tessari | Chief Strategy Officer |
Mr. Michael R. Megna CPA | Senior VP & Chief Accounting Officer |
Ms. Mei Jang | Senior Vice President of Technical Operations |
Mr. Douglas Barry | Senior VP, Chief Legal Officer & Secretary |
Mr. Mark A. Ragosa C.F.A. | Senior VP & CFO |
Mr. Ross Michael Moat | COO & Principal Operating Officer |
Dr. John F. Paolini FACC, M.D., Ph.D. | Executive VP & Chief Medical Officer |
Kiniksa Pharmaceuticals International Plc share price today is $43.32 as on . Kiniksa Pharmaceuticals International Plc share today touched a day high of $44.97 and a low of $43.02.
Kiniksa Pharmaceuticals International Plc share touched a 52 week high of $44.66 on and a 52 week low of $18.12 on . Kiniksa Pharmaceuticals International Plc stock price today i.e. is trending at $43.32,which is 3.00% down from its 52 week high and 139.07% up from its 52 week low.
Kiniksa Pharmaceuticals International Plc market capitalisation is $0.00T as on .
Indian investors can start investing in Kiniksa Pharmaceuticals International Plc (KNSA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Kiniksa Pharmaceuticals International Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kiniksa Pharmaceuticals International Plc share’s latest price of $43.32 as on January 28, 2026 at 9:37 pm IST, you will get 0.2308 shares of Kiniksa Pharmaceuticals International Plc. Learn more about
fractional shares .
Kiniksa Pharmaceuticals International Plc stock has given 134.45% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?